RNA Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • RNA Diagnostics's estimated annual revenue is currently $2.8M per year.(i)
  • RNA Diagnostics's estimated revenue per employee is $251,000

Employee Data

  • RNA Diagnostics has 11 Employees.(i)
  • RNA Diagnostics grew their employee count by -8% last year.

RNA Diagnostics's People

NameTitleEmail/Phone
1
EVP Corporate DevelopmentReveal Email/Phone
2
VP Operations and R&DReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Director Clinical DevelopmentReveal Email/Phone
6
President/CEOReveal Email/Phone
7
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is RNA Diagnostics?

Rna Diagnostics Inc. is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, RNA Disruption Assayâ„¢ (RDAâ„¢), is a novel test that helps oncologists to rapidly assess the effectiveness of cancer chemotherapy. RDA can determine whether chemotherapy is working effectively in the individual patient early in treatment thereby guiding clinical decision making.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$2.8M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RNA Diagnostics News

2022-04-20 - Co-Diagnostics, Inc. JV CoSara Receives Clearance from ...

The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The...

2022-04-13 - Signatures of certain RNA molecules may help improve ...

New research by Massachusetts General Hospital (MGH), US revealed that cells often release certain RNA molecules in response to stressors. The...

2022-04-06 - RNA Disease Diagnostics Expands Board of Directors

Lead Co-Inventor and Licensor of RNADD's Molecular Diagnostics Platform to Help Guide its Commercialization -.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M110%N/A
#2
$0.4M110%$21.5M
#3
$1M110%N/A
#4
$1M11N/AN/A
#5
$1M11N/AN/A